肾癌伴下腔静脉癌栓行肾切除及取栓术后症状性静脉血栓栓塞与生存预后关系
该回顾性研究纳入2000至2010年间183例因肾细胞癌行肾切除联合下腔静脉癌栓切除术的患者,术后症状性静脉血栓栓塞发生率为17%(30天)、22%(90天)、27%(365天)。多因素分析显示,症状性静脉血栓栓塞与全因死亡风险增加独立相关(HR 1.53,95%CI 1.04-2.23,p=0.029)。
要点
- 术后90天内静脉血栓栓塞累积发生率为22%,需加强早期监测。
- 吸烟史、ECOG评分≥1、高凝状态及淋巴结肿大显著增加血栓风险。
- 症状性静脉血栓栓塞与全因死亡风险增加独立相关(HR 1.53)。
核心结论
- 肾切除联合下腔静脉癌栓切除术后90天内静脉血栓栓塞常见,症状性血栓栓塞与全因死亡风险增加独立相关(HR 1.53,95%CI 1.04-2.23,p=0.029)。
研究设计与样本
- 回顾性队列研究,纳入183例2000至2010年间因肾细胞癌行肾切除联合下腔静脉癌栓切除术(I-IV级)的患者。
主要发现
- 55例患者术后中位23天(IQR 5-142)发生症状性静脉血栓栓塞,包括肺血栓24例、深静脉血栓17例、下腔静脉血栓13例、门静脉血栓1例。
- 术后30天、90天和365天静脉血栓栓塞累积发生率分别为17%、22%和27%。
- 多因素分析显示,吸烟史(HR 2.15,95%CI 1.09-4.24,p=0.028)、ECOG体能状态≥1(HR 2.15,95%CI 1.17-3.93,p=0.013)、高凝状态(HR 5.12,95%CI 1.93-13.59,p=0.001)及术中淋巴结肿大(HR 4.84,95%CI 1.87-12.51,p=0.001)与静脉血栓栓塞风险增加显著相关。
临床怎么用
- 术后90天内应警惕症状性静脉血栓栓塞,尤其对具有吸烟史、ECOG评分≥1、高凝状态或淋巴结肿大的患者加强监测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: We investigated the incidence and survival impact of symptomatic venous thromboembolism after nephrectomy with inferior vena cava tumor thrombectomy. MATERIALS AND METHODS: We retrospectively reviewed the records of 183 patients who underwent nephrectomy with inferior vena cava tumor thrombectomy (level I-IV) for renal cell carcinoma between 2000 and 2010. Postoperative venous thromboembolism was defined as symptomatic bland thrombus or embolism confirmed on imaging. The cumulative incidence of venous thromboembolism was estimated by the Kaplan-Meier method. Associations of clinicopathological features with time to thromboembolism after surgery and all cause mortality were evaluated on multivariable analysis with Cox models. RESULTS: Symptomatic venous thromboembolism developed in 55 patients a median of 23 days (IQR 5-142) postoperatively, including pulmonary thrombosis in 24, deep venous thrombosis in 17, bland inferior vena cava thrombosis in 13 and portal vein thrombosis in 1. The cumulative incidence of thromboembolism 30, 90 and 365 days following surgery was 17%, 22% and 27%, respectively. A history of smoking (HR 2.15, 95% CI 1.09-4.24, p = 0.028), ECOG (Eastern Cooperative Oncology Group) performance status 1 or greater (HR 2.15, 95% CI 1.17-3.93, p = 0.013), hypercoagulability disorder (HR 5.12, 95% CI 1.93-13.59, p = 0.001) and bulky lymphadenopathy at surgery (HR 4.84, 95% CI 1.87-12.51, p = 0.001) was significantly associated with an increased risk of venous thromboembolism on multivariable analysis. Postoperative venous thromboembolism was significantly associated with an increased risk of all cause mortality (HR 1.53, 95% CI 1.04-2.23, p = 0.029). CONCLUSIONS: Venous thromboembolism after nephrectomy and tumor thrombectomy is common within 90 days of surgery. Symptomatic venous thromboembolism in this population is independently associated with a greater risk of mortality.
引用
- Shah PH, Thompson RH, Boorjian SA, et al. Symptomatic Venous Thromboembolism is Associated with Inferior Survival among Patients Undergoing Nephrectomy with Inferior Vena Cava Tumor Thrombectomy for Renal Cell Carcinoma. J Urol. 2018. PMID: 29709665. doi:10.1016/j.juro.2018.04.069
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。